Chronic Fatigue Syndrome | Myalgic Encephalomyelitis – Neurobiology | Diagnosis | Management
Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) is a disabling and complex clinical condition characterised by unexplained and persistent post-exertional fatigue along with cognitive, immunological, endocrinological and autonomic dysfunction.
There is an overlap between Long Covid and CFS / ME symptomatology.
There have been several consensus research and clinical definitions to describe CFS; e.g. Fukuda, Holmes, International Consensus Criteria (ICC), Oxford, Canadian Consensus Criteria (CCC), Australian, Ramsay and Systemic Exertion Intolerance Disease (SEID).
Researchers have extensively used the Fukuda CFS case definition for the past two decades. [Fukuda et al., 1994]
One of the limitations of the Fukuda criteria is that some individuals who meet the criteria do not have core symptoms of the illness, such as post-exertional malaise, unrefreshing sleep, or memory/concentration problems. Its use is also prone to misdiagnosis or overdiagnosis.
On the other hand, the Canadian ME/CFS criteria identify a smaller subset of patients with more severe functional impairment and post-exertional malaise symptoms. [Carruthers et al., 2003], [Jason et al., 2014]
Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles ACP, Sherkey JA, van de Sande MI. Myalgic Encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatments protocols. J Chronic Fatigue Syndr. 2003;11:7–115.
Nunez M, Fernandez Sola J, Nunez E, Fernandez‐Huerta JM, Godas‐Sieso T, Gomez‐Gil E (2011). Health‐related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow up. Clin Rheumatol 30: 381–389.
White, P. D., Goldsmith, K. A., Johnson, A. L., Potts, L., Walwyn, R., DeCesare, J. C., … & PACE Trial Management Group. (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. The Lancet, 377(9768), 823-836.
Wilshire, C., Kindlon, T., Matthees, A. and McGrath, S., 2017. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial. Fatigue: Biomedicine, Health & Behavior, 5(1), pp.43-56.
Zachrisson, O., Colque-Navarro, P., Gottfries, C. G., Regland, B., & Möllby, R. (2004). Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement. European Journal of Clinical Microbiology and Infectious Diseases, 23(2), 98-105.
Kpaeyeh Jr., J., Mar, P.L., Raj, V., Black, B.K., Arnold, A.C., Biaggioni, I., Shibao, C.A., Paranjape, S.Y., Dupont, W.D., Robertson, D., Raj, S.R., 2014. Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial. J. Clin. Psychopharmacol. 34, 738–741
Castro-Marrero, J., Zaragozá, M. C., Domingo, J. C., Martinez-Martinez, A., Alegre, J., & von Schacky, C. (2018). Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Prostaglandins, Leukotrienes and Essential Fatty Acids, 139, 20-24.